|
PIGS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.825950E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.170300E-04 |
| Normal-vs-Stage2 |
6.755600E-01 |
| Normal-vs-Stage3 |
1.847520E-04 |
| Normal-vs-Stage4 |
7.62960000000312E-05 |
| Stage1-vs-Stage2 |
9.467700E-02 |
| Stage1-vs-Stage3 |
4.564800E-01 |
| Stage1-vs-Stage4 |
2.110400E-01 |
| Stage2-vs-Stage3 |
4.845800E-02 |
| Stage2-vs-Stage4 |
2.189900E-02 |
| Stage3-vs-Stage4 |
4.858800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.358400E-04 |
| Normal-vs-AfricanAmerican |
1.458600E-01 |
| Normal-vs-Asian |
6.399300E-03 |
| Caucasian-vs-AfricanAmerican |
3.353400E-01 |
| Caucasian-vs-Asian |
9.468800E-01 |
| AfricanAmerican-vs-Asian |
4.116600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.166730E-04 |
| Normal-vs-Female |
9.195100E-04 |
| Male-vs-Female |
1.239640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.464810E-03 |
| Normal-vs-Age(41-60Yrs) |
9.019900E-04 |
| Normal-vs-Age(61-80Yrs) |
4.938300E-03 |
| Normal-vs-Age(81-100Yrs) |
7.642300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.933400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.503000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.063200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.479600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.834800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.210600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.290060E-02 |
| Classical-VS-Follicular |
5.694400E-01 |
| Classical-VS-Other |
3.868200E-02 |
| Classical-VS-Normal |
1.663790E-03 |
| Tall-VS-Follicular |
2.502400E-02 |
| Tall-VS-Other |
2.328000E-01 |
| Tall-VS-Normal |
1.94054999999027E-05 |
| Follicular-VS-Other |
1.242350E-01 |
| Follicular-VS-Normal |
6.499800E-02 |
| Other-VS-Normal |
4.954000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.202200E-03 |
| Normal-vs-N1 |
2.32519999998626E-06 |
| N0-vs-N1 |
2.635600E-03 |
|
|
